Since Sp1 sites within the COL7A1 promoter play a crucial role in gene expression, it becomes essential to analyze these sites when a second mutation cannot be identified in the coding or intronic sequences of a patient with RDEB. The gene discussed is SP1; the disease is recessive dystrophic epidermolysis bullosa.